| # | Drug | Count |
|---|---|---|
| 0 | NILOTINIB | 71 |
| 1 | DASATINIB | 33 |
| 2 | IMATINIB | 26 |
| 3 | METHOTREXATE | 14 |
| 4 | METHOTREXATE SODIUM | 14 |
| 5 | ASPIRIN | 13 |
| 6 | ASPIRIN 325 MG | 13 |
| 7 | ASPIRIN 81 MG | 13 |
| 8 | NIRSEVIMAB | 12 |
| 9 | PREDNISONE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIRSEVIMAB | 12 | 0.0067 |
| 1 | SACCHAROMYCES CEREVISIAE | 6 | 0.0065 |
| 2 | TALIMOGENE LAHERPAREPVEC | 7 | 0.0044 |
| 3 | DASATINIB | 33 | 0.0036 |
| 4 | NILOTINIB | 71 | 0.0024 |
| 5 | CARBAMIDE PEROXIDE | 1 | 0.0023 |
| 6 | MARIBAVIR | 4 | 0.0016 |
| 7 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 8 | ASCIMINIB | 3 | 0.0009 |
| 9 | ADENOSINE | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 12 | 0.0067 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Non-Standardized Fungal Allergenic Extract [EPC] | 6 | 0.0028 |
| 3 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 4 | 0.0016 |
| 4 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 5 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 6 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 7 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 9 | Ergot Derivative [EPC] | 1 | 0.0002 |